Evidence map›Paper›PMID 32797166›Full record

ArticleNucleic acids research2020

FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.

Sanket Awate, Joshua A Sommers, Arindam Datta, Sumeet Nayak, Marina A Bellani, Olivia Yang, Christopher A Dunn, Claudia M Nicolae, George-Lucian Moldovan, Michael M Seidman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. The anti-tumor and renoprotection study of E-[c(RGDfK)Journal of nanobiotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sanket AwateLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Joshua A SommersLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Arindam DattaLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Sumeet NayakDepartment of Cancer Biology, University of Massachusetts Medical School - UMASS Memorial Cancer Center, Worcester, MA, USA.
Marina A BellaniLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Olivia YangDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University, Baltimore, MD, USA.
Christopher A DunnFlow Cytometry Unit, National Institute on Aging, NIH, Baltimore, MD, USA.
Claudia M NicolaeDepartment of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA, USA.
George-Lucian MoldovanDepartment of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA, USA.
Michael M SeidmanLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Sharon B CantorDepartment of Cancer Biology, University of Massachusetts Medical School - UMASS Memorial Cancer Center, Worcester, MA, USA.
Robert M BroshLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
National Institute on Aging · USPenn State Milton S. Hershey Medical Center · USUniversity of Massachusetts Chan Medical School · USJohns Hopkins University · US

Funding

Repair of localized DNA damageZIAAG000746 · NIA · NATIONAL INSTITUTE ON AGING · PI SEIDMAN, MICHAEL · 2009 to 2025
$30.0M
Fanconi Anemia PathwayZIAAG000753 · NIA · NATIONAL INSTITUTE ON AGING · PI BROSH, ROBERT · 2009 to 2025
$4.3M
The Role of Mono-ADP-Ribosylation by PARP14 in RadioresistanceR01ES026184 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI George Lucian Moldovan · 2016 to 2026
$3.6M
FANCJ dependent pathways in replication stressR01CA225018 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CANTOR, SHARON B · 2018 to 2022
$1.9M
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian CancerR01CA176166 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CANTOR, SHARON B · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA176166NCI NIH HHS R01 CA225018NIEHS NIH HHS R01 ES026184
6 · The paper itself

Abstract

FANCJ, a DNA helicase and interacting partner of the tumor suppressor BRCA1, is crucial for the repair of DNA interstrand crosslinks (ICL), a highly toxic lesion that leads to chromosomal instability and perturbs normal transcription. In diploid cells, FANCJ is believed to operate in homologous recombination (HR) repair of DNA double-strand breaks (DSB); however, its precise role and molecular mechanism is poorly understood. Moreover, compensatory mechanisms of ICL resistance when FANCJ is deficient have not been explored. In this work, we conducted a siRNA screen to identify genes of the DNA damage response/DNA repair regime that when acutely depleted sensitize FANCJ CRISPR knockout cells to a low concentration of the DNA cross-linking agent mitomycin C (MMC). One of the top hits from the screen was RAP80, a protein that recruits repair machinery to broken DNA ends and regulates DNA end-processing. Concomitant loss of FANCJ and RAP80 not only accentuates DNA damage levels in human cells but also adversely affects the cell cycle checkpoint, resulting in profound chromosomal instability. Genetic complementation experiments demonstrated that both FANCJ's catalytic activity and interaction with BRCA1 are important for ICL resistance when RAP80 is deficient. The elevated RPA and RAD51 foci in cells co-deficient of FANCJ and RAP80 exposed to MMC are attributed to single-stranded DNA created by Mre11 and CtIP nucleases. Altogether, our cell-based findings together with biochemical studies suggest a critical function of FANCJ to suppress incompletely processed and toxic joint DNA molecules during repair of ICL-induced DNA damage.

Indexed as

BRCA1 ProteinChromosomal InstabilityDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA RepairFanconi Anemia Complementation Group ProteinsGene Knockout TechniquesGenomic InstabilityHeLa CellsHistone ChaperonesHumansMitomycinRad51 RecombinaseRecombinational DNA RepairRNA HelicasesBRCA1 ProteinBRCA1 protein, humanBRIP1 protein, humanDNA-Binding ProteinsFanconi Anemia Complementation Group ProteinsHistone ChaperonesMitomycinRad51 RecombinaseRNA HelicasesUIMC1 protein, human

Identifiers

PMID32797166
PMCPMC7498338
OpenAlexW3049525768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.